SPY768.27QQQ737.78−0.90%BTC/USD82,970.38−1.75%DIA516.08−0.27%GLD381.16−3.11%TLT79.06−0.33%
Benzinga

Cormedix Inc (CRMD) Stock Price, Quote, News & History

CRMDNASDAQ
Trade with Public
Trade with Public
$7.85
0.081.03%
At close: Sep 24, 5:00 PM EST
$7.85
0.081.03%
Pre-Market: 4:01 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Cormedix (CRMD) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
$7.85
Volume / Avg.
0 / 1.17M
Day Range
- - -
52 Wk Range
6.13 - 13.02
Market Cap
$611.86M
P/E Ratio
3.60
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
21.07%
Days to Cover
18.49

Recent CorMedix Inc. News

CorMedix Stock Jumps on Strong DefenCath Sales

CorMedix Q2 earnings beat estimates as sales more than doubled, DefenCath revenue grew, and the company reaffirmed 2026 sales guidance.
Vandana Singh

Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday

Nasdaq Composite gained 200 points on Thursday, while Accelerant Holdings (NYSE: ARX) rose 44.2% after being acquired by Thoma Bravo and reporting strong Q2 results. Other top gainers include Omeros Corp (NASDAQ: OMER), CorMedix Inc (NASDAQ: CRMD), and Hyliion Holdings Corp (NYSE: HYLN).
Avi Kapoor

Frequency Electronics Posts Weak Q4 Results, Joins AST SpaceMobile And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

US stock futures mixed, Dow futures up 0.2%. Frequency Electronics (FEIM) shares down 8.3% after reporting Q4 losses. Other stocks also lower in pre-market.
Avi Kapoor

Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

US stock futures lower as Dow falls 100 points. Nike shares down 4% after Q4 results. Shutterstock, Optimum Communications, Cronos, and others also drop.
Avi Kapoor

CorMedix Stock Jumps As DefenCath Fuels Q1 Beat, 2026 Outlook Raised

CorMedix raises 2026 guidance after Q1 revenue surges on strong DefenCath demand and higher profitability.
Vandana Singh
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
253.94M
Investing Cash Flow (TTM)
-285.62M
Financing Cash Flow (TTM)
129.95M
Free Cash Flow (TTM)
250.42M
Capital Expenditure (TTM)
-3.52M
Net Change in Cash (TTM)
98.27M

Analyst Trends and Forecast

4
Apr
1
Jul
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$500.32M
PE Ratio (TTM)
3.60
PE Ratio (FWD)
56.18
PEG Ratio (TTM)
5.61
PS Ratio (TTM)
1.57
PB Ratio (TTM)
1.33
Earnings Yield % (TTM)
27.77%
Earnings Yield % (FWD)
1.78%
EV / EBITDA (TTM)
1.96
Price / EBITDA (TTM)
2.81
Price / Free Cash Flow (TTM)
2.87
Book Value / Share
$5.91

Company Debt

Total Debt
$145.15M
LT Debt
$145.15M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$256.69M
Debt to Equity
0.31
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$7.85
Volume / Avg.
0 / 1.17M
Day Range
- - -
52 Wk Range
6.13 - 13.02
Market Cap
$611.86M
P/E Ratio
3.60
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
21.07%
Days to Cover
18.49

About

Sector
Health Care
Industry
Pharmaceuticals
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States a...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Cormedix (CRMD) stock?

A

You can purchase shares of Cormedix (NASDAQ:CRMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cormedix (CRMD) competitors?

Q

What is the forecast, or price target, for Cormedix (CRMD) stock?

A

Cormedix has a consensus price target of $15.58.

Q

What is the current price for Cormedix (CRMD)?

A

The stock price for Cormedix (NASDAQ: CRMD) is $7.85 last updated September 25, 2026 at 4:00 PM EDT.

Q

Does Cormedix (CRMD) pay a dividend?

A

There are no upcoming dividends for Cormedix.

Q

When is Cormedix (NASDAQ:CRMD) reporting earnings?

A

Cormedix does not have any upcoming earnings scheduled.

Q

Is Cormedix (CRMD) going to split?

A

There is no upcoming split for Cormedix.

Q

What sector and industry does Cormedix (CRMD) operate in?

A

Cormedix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved